Tag: AMD
Meaningful Support in Geographic Atrophy: How Optometrists Guide AMD Patients and...
Vision loss is never a purely clinical journey. As Dr. Jennifer Lyerly shares at the start of this Defocus Media episode, geographic atrophy affects patients emotionally, socially, and psychologically. Optometrists, therefore, play a central role in offering meaningful support throughout the entire geographic atrophy experience—especially as new treatment options, including Izervay, enter the landscape.
Geographic Atrophy: A Comprehensive Guide for Eye Care Professionals
n this article, featuring insights from expert guests Dr. James Fanelli and Dr. Roya Attar, we will explore the nature of Geographic Atrophy, its diagnosis, patient education, and current treatment options, offering eye care professionals actionable insights to serve their patients better.
Hyperopia and the correlation with AMD.
A new study examined the relationship between AMD and refractive error.
The study details:
The study examined 196 eyes (of 98 patients) in a Turkish population, all whom...
The PRO-CON study.
The question:Â If my patient has wet AMD in one eye, would prophylactic intravitreal injections in the other eye prevent wet AMD from developing?
Why did...
Study examining metformin use and AMD.
The question:Â Can metformin use decrease the risk of AMD?
Maybe. New research from Taiwan examined the data of over 68,000 patients diagnosed with diabetes from 2001-2013....
The LADDER study.
The question:Â Can we use a port system to deliver anti-VEGF for wet AMD instead of doing monthly injections?
In the LADDER trial (Long-Acting Delivery of...
What your patient might ask you…
Can what I eat make my AMD worse?
There is growing evidence suggesting it can.
A collaboration of researchers in Europe found that patients that adhere to a...
What your patient might ask you…
Will taking aspirin make my wet AMD worse?
A new study published in Ophthalmology says no.
The study reviewed the medical data of over 400,000 patients from 2010-2015...
What your patient might ask you…
Is there any new research for patients with dry AMD?
Thankfully, yes. Apellis Pharmaceuticals has started it's phase 3 trial studying the effects of APL-2...






